{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:55:37Z","timestamp":1793141737579,"version":"4.5.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T00:00:00Z","timestamp":1334188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034805","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T21:11:33Z","timestamp":1334265093000},"page":"e34805","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":115,"title":["SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo"],"prefix":"10.1371","volume":"7","author":[{"given":"Anna","family":"Bobrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Donmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Guarente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington&apos;s disease.","volume":"369","author":"FO Walker","year":"2007","journal-title":"The Lancet"},{"key":"ref2","article-title":"Huntington&apos;s disease","author":"G Bates","year":"2002"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","article-title":"Huntington&apos;s disease.","volume":"340","author":"MJ Novak","year":"2010","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.","volume":"60","author":"HD Rosas","year":"2003","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington&apos;s disease.","volume":"44","author":"JP Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington&apos;s disease: clinical presentation and treatment.","volume":"98","author":"MJ Novak","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&apos;s disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/nen.0b013e318040b2c8","article-title":"Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models.","volume":"66","author":"G Schilling","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington&apos;s disease.","volume":"90","author":"C Zuccato","year":"2010","journal-title":"Physiol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family.","volume":"370","author":"AJ de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins.","volume":"460","author":"T Finkel","year":"2009","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11927","DOI":"10.1021\/jp1054183","article-title":"Investigation of the catalytic mechanism of Sir2 enzyme with QM\/MM approach: SN1 vs SN2?","volume":"114","author":"Z Liang","year":"2010","journal-title":"J Phys Chem B"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington&apos;s disease.","volume":"41","author":"T Hathorn","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.2559","article-title":"Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.","volume":"18","author":"H Jeong","year":"2012","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.","volume":"11","author":"BJ North","year":"2003","journal-title":"Mol Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1371\/journal.pone.0000784","article-title":"Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.","volume":"2","author":"BJ North","year":"2007","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1101\/gad.1412706","article-title":"SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis.","volume":"20","author":"A Vaquero","year":"2006","journal-title":"Genes Dev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molcel.2011.04.028","article-title":"Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.","volume":"43","author":"W Jiang","year":"2011","journal-title":"Mol Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1474-9726.2007.00304.x","article-title":"SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.","volume":"6","author":"F Wang","year":"2007","journal-title":"Aging Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1091\/mbc.E08-06-0647","article-title":"SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1&apos;s repressive interaction with PPARgamma.","volume":"20","author":"F Wang","year":"2009","journal-title":"Mol Biol Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-09-0971","article-title":"SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.","volume":"9","author":"B Peck","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington&apos;s disease.","volume":"17","author":"J Pallos","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.","volume":"107","author":"R Luthi-Carter","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","article-title":"Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease.","volume":"121","author":"J Labbadia","year":"2011","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.","volume":"285","author":"C Landles","year":"2010","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","article-title":"Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington&apos;s disease.","volume":"19","author":"K Sathasivam","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes.","volume":"72","author":"B Woodman","year":"2007","journal-title":"Brain Res Bull"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington&apos;s disease.","volume":"4","author":"H Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin&apos;s effects on striatal gene expression in mice recapitulate changes observed in human Huntington&apos;s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.","volume":"16","author":"A Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1093\/hmg\/ddr326","article-title":"The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.","volume":"20","author":"MM Maxwell","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref31","article-title":"Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.","author":"F Wang","year":"2011","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.emboj.7600570","article-title":"Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.","volume":"24","author":"Y Yang","year":"2005","journal-title":"EMBO J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e20696","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington&apos;s disease.","volume":"6","author":"A Bobrowska","year":"2011","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington&apos;s disease.","volume":"4","author":"SE Andrew","year":"1993","journal-title":"Nat Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington&apos;s disease mice.","volume":"51","author":"E Hockly","year":"2002","journal-title":"Ann Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2005.07.007","article-title":"Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington&apos;s disease.","volume":"21","author":"E Hockly","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington&apos;s disease: can mice lead the way to treatment?","volume":"69","author":"ZR Crook","year":"2011","journal-title":"Neuron"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1021\/jm050522v","article-title":"Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.","volume":"48","author":"AD Napper","year":"2005","journal-title":"J Med Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington&apos;s disease.","volume":"28","author":"M Valenza","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.","volume":"28","author":"Y Zhang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1128\/MCB.23.9.3173-3185.2003","article-title":"Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.","volume":"23","author":"SC Dryden","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.onc.1209857","article-title":"SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.","volume":"26","author":"T Inoue","year":"2007","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1083\/jcb.200707126","article-title":"The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.","volume":"180","author":"R Pandithage","year":"2008","journal-title":"J Cell Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/sj.onc.1210617","article-title":"NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.","volume":"26","author":"A Vaquero","year":"2007","journal-title":"Oncogene"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson&apos;s disease.","volume":"317","author":"TF Outeiro","year":"2007","journal-title":"Science"},{"key":"ref47","first-page":"65","article-title":"Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells.","volume":"3","author":"H Nie","year":"2011","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmet.2007.07.003","article-title":"SIRT2 regulates adipocyte differentiation through FoxO1 acetylation\/deacetylation.","volume":"6","author":"E Jing","year":"2007","journal-title":"Cell Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e8322","DOI":"10.1371\/journal.pone.0008322","article-title":"Hypothalamic Sirt1 regulates food intake in a rodent model system.","volume":"4","author":"I Cakir","year":"2009","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy.","volume":"8","author":"DG Hardie","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.","volume":"458","author":"C Canto","year":"2009","journal-title":"Nature"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.","volume":"125","author":"RK Graham","year":"2006","journal-title":"Cell"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e5747","DOI":"10.1371\/journal.pone.0005747","article-title":"Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington&apos;s disease.","volume":"4","author":"CL Benn","year":"2009","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e31080","DOI":"10.1371\/journal.pone.0031080","article-title":"Genetic Knock-Down of <italic>Hdac3<\/italic> Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington&apos;s Disease.","volume":"7","author":"L Moumn\u00e9","year":"2012","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington&apos;s disease through activation of multiple Sirt1 targets.","volume":"18","author":"M Jiang","year":"2011","journal-title":"Nat Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse.","volume":"61","author":"E Hockly","year":"2003","journal-title":"Brain Res Bull"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins.","volume":"56","author":"J Ko","year":"2001","journal-title":"Brain Res Bull"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","article-title":"Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington&apos;s disease.","volume":"395","author":"A Weiss","year":"2009","journal-title":"Anal Biochem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/hmg\/10.21.2425","article-title":"Centrosome disorganization in fibroblast cultures derived from R6\/2 Huntington&apos;s disease (HD) transgenic mice and HD patients.","volume":"10","author":"K Sathasivam","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington&apos;s disease.","volume":"3","author":"CL Benn","year":"2008","journal-title":"Mol Neurodegener"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0248926","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:25:17Z","timestamp":1540214717000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034805"}},"subtitle":[],"editor":[{"given":"Hitoshi","family":"Okazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,12]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034805","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0248926","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,12]]}}}